Status of the p53, Rb and Mdm2 genes in canine osteosarcoma

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4449-4453

  Mendoza, Susana ^a   Konishi, Tamiko ^a   Dernell, William S ^b   Withrow, Stephen J ^b   Miller, Carl W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Dogs; MDM2; Osteosarcoma; p53; Rb

Indexed keywords

PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG DISEASE; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENE STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ANIMALS; BONE NEOPLASMS; DOG DISEASES; DOGS; FRAMESHIFT MUTATION; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; LIVER; MALE; MANDIBULAR NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OSTEOSARCOMA; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENES; SEQUENCE DELETION; TESTIS; TUMOR CELLS, CULTURED;

EID: 0032410963     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mertens WC, Bramwell VC: Osteosarcoma and other tumors of bone. Curr Opin Oncol 9: 360-365, 1997.
2. Withrow SJ, Powers BE, Straw RC, Wilkins RM: Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop 270: 159-168, 1991.
3. Whelan JS: Osteosarcoma. Eur J Cancer 33: 1611-1619, 1997.
4. Moll AC; Imhof SM, Bouter LM, Tan KE: Second primary tumors in patients with retinoblastoma. A review ofthe literature. Ophthalmic Genet 18: 27-34, 1997.
5. Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nakamura Y, Sasaki MS and Ishizaki K: Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52: 2419-2423, 1992.
6. Araki N, Uchida A, Kimura T, Yoshikawa H, Aoki Y, Ueda T, Takai Saoiki T, and Ono K: Involvement of the retinoblastoma gene in primary osteosarcomas and otherbone and soft-tissue tumors.. Clin. Orthop 270: 271-277, 1991.
7. Reissmann PT, Simon MA, Lee WH, Slamon DJ: Studies of the retinoblastoma gene in human sarcomas. Oncogene 4: 839-843, 1989.
8. Miller C W, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP: Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Onco 122: 559-565, 1996.
9. Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS, Carbone M: Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63: 37-50, 1996.
10. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, and Yamamuro T: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-8, 1994.
11. Ozaki T, Ikeda S, Kawai A, Inoue H and Oda T: Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors. Cell Molec Biol 39: 235-242.
12. Xu HJ, Hu SX, Hashimoto T, Takahashi R and Benedict WF: The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 4: 807-812, 1989.
13. Shew JY, Ling N, Yang XM, Fodstad O and Lee WH: Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (ppl 10RB) in osteosarcomas and synovial sarcomas. Oncogene Res 4: 205-214, 1989.
14. Palmero I and Peters G: Perturbation of cell cycle regulators in human cancer. Cancer Surv 27: 351-367, 1996.
15. Masuda H, Miller C, Koeffler HP, Battifora H, and Cline MJ: Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. (USA) 84: 7716-7719, 1987.
16. Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B and Koeffer HP: Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50: 7950-7954, 1990.
17. Levine AJ: p53, the cellular gatekeeper for growth and division.Cell 88: 323-31, 1997.
18. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA and Friend S: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238, 1990.
19. Evans SC and Lozano G: The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Mol Med Today 3: 390-5, 1997.
20. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS and Little JB: Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52: 6194-6199, 1992.